C-A3-01: Current Use of KRAS Testing in Clinical Practice

BACKGROUND/AIMS: Provisional clinical guidelines, published by the American Society of Clinical Oncology in 2009, recommend that patients with metastatic colon cancer (mCRC) be tested for mutations in the Kirsten ras (KRAS) oncogene, and that patients found to have the non mutated KRAS gene be offer...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Somkin, Carol, Liljestrand, Petra, Harris, Julie, Kolevska, Tatjana, Alexander, Gwen, Kauffman, Tia, McCarty, Catherine, O’Neil, Suzanne, Pawloski, Pamala, Rahm, Alanna, Williams, Andrew, Goddard, Katrinna
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Marshfield Clinic 2011
Gaiak:
SELECTED ABSTRACTS - HMORN 2011: Mega-Epidemiology and Genetics
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251460/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2011.1020.c-a3-01
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak